Clinical Trials

Blog Post

Capricor Therapeutics Announces Positive Interim Results from Phase 2 Study of CAP-1002 to Treat DMD

By Jeanene Swanson | October 29, 2019
Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

ReveraGen Presents Positive Interim Results from Phase 2 Extension Study of Vamorolone to Treat DMD in Young Boys

By Jeanene Swanson | October 21, 2019
Blog Post

NS Pharma Submits New Drug Application to FDA for Viltolarsen to Treat DMD Amenable to Exon 53 Skipping

By Jeanene Swanson | October 7, 2019
MDA logo
Blog Post

In a Letter to the Duchenne Community, Santhera Announces Positive Results of Phase 2 Vamorolone Study, EMA’s Review of Puldysa to Treat Symptoms of DMD

By MDA Staff | September 26, 2019
Blog Post

Clinical Trial Alert: Italfarmaco Seeks Participants for a Phase 3 DMD Study

By MDA Staff | September 25, 2019
Blog Post

Participants Needed for a Pilot Study of a New Diagnostic Device

By MDA Staff | September 19, 2019
baby girl
Blog Post

Biogen Announces Positive Long-Term Results from Phase 2 Study of Spinraza to Treat SMA in Pre-Symptomatic Infants

By Jeanene Swanson | August 21, 2019
Blog Post

The ALS Association, ALS Finding A Cure, and MDA Co-Fund Clinical Trial Grant to Study Restoring Immune System Function to Treat ALS

By Jeanene Swanson | August 9, 2019
Blog Post

Scholar Rock Announces Positive Results from Phase 1 Study of SRK-015 to Treat SMA

By Jeanene Swanson | August 7, 2019